Sihong Huang1,2,3, Stephen C Cook4,5,6. 1. Congenital Heart Center, Spectrum Health Helen DeVos Children's Hospital, 100 Michigan Street NE (MC248), Grand Rapids, MI, 49503, USA. 2. Pediatrics and Human Development, Michigan State University College of Human Medicine, 15 Michigan NE, Grand Rapids, MI, USA. 3. Congenital Heart Center, MC 248, 25 Michigan Street NE, Suite 4200, Grand Rapids, MI, 49503, USA. 4. Congenital Heart Center, Spectrum Health Helen DeVos Children's Hospital, 100 Michigan Street NE (MC248), Grand Rapids, MI, 49503, USA. stephen.cook@helendevoschildrens.org. 5. Pediatrics and Human Development, Michigan State University College of Human Medicine, 15 Michigan NE, Grand Rapids, MI, USA. stephen.cook@helendevoschildrens.org. 6. Congenital Heart Center, MC 248, 25 Michigan Street NE, Suite 4200, Grand Rapids, MI, 49503, USA. stephen.cook@helendevoschildrens.org.
Abstract
PURPOSE OF THE REVIEW: To review the current state of literature on sexual dysfunction in adults with congenital heart disease (ACHD). RECENT FINDINGS: The prevalence of sexual dysfunction in ACHD is approximately 28%. Compared to age-matched cohorts, the prevalence of sexual dysfunction among ACHD cohorts demonstrates significant variability. ACHD have a lower rate of ever having sexual intercourse and often at a later age. Regardless of complexity, ACHD with sexual dysfunction have higher level of distress, decreased quality of life, and worse New York Heart Association classification. Patients, including heart failure and ACHD, treated with dual angiotensin receptor neprilysin inhibitor have reported improved sexual relationships. The prevalence of sexual dysfunction in ACHD patients is high and sexual dysfunction research in ACHD remains limited. Therefore, the relationship between sexual dysfunction and ACHD remains ill-defined. Cardiologists that participate in the care of these patients should proactively discuss sexual health and provide counseling and therapies to provide high-quality healthcare for ACHD.
PURPOSE OF THE REVIEW: To review the current state of literature on sexual dysfunction in adults with congenital heart disease (ACHD). RECENT FINDINGS: The prevalence of sexual dysfunction in ACHD is approximately 28%. Compared to age-matched cohorts, the prevalence of sexual dysfunction among ACHD cohorts demonstrates significant variability. ACHD have a lower rate of ever having sexual intercourse and often at a later age. Regardless of complexity, ACHD with sexual dysfunction have higher level of distress, decreased quality of life, and worse New York Heart Association classification. Patients, including heart failure and ACHD, treated with dual angiotensin receptor neprilysin inhibitor have reported improved sexual relationships. The prevalence of sexual dysfunction in ACHD patients is high and sexual dysfunction research in ACHD remains limited. Therefore, the relationship between sexual dysfunction and ACHD remains ill-defined. Cardiologists that participate in the care of these patients should proactively discuss sexual health and provide counseling and therapies to provide high-quality healthcare for ACHD.
Entities:
Keywords:
Adult congenital heart disease; Assessment; Congenital heart disease; Counseling; Sexual function; Sexual health
Authors: Michiel M Winter; Claire Reisma; Harald Kedde; Berto J Bouma; Jeroen C Vis; Paul Luijendijk; Piet de Witte; Aielko H Zwinderman; Hubert W Vliegen; Petronella G Pieper; Arie P J van Dijk; Barbara J M Mulder Journal: Am J Cardiol Date: 2010-10-15 Impact factor: 2.778
Authors: Glenn N Levine; Elaine E Steinke; Faisal G Bakaeen; Biykem Bozkurt; Melvin D Cheitlin; Jamie Beth Conti; Elyse Foster; Tiny Jaarsma; Robert A Kloner; Richard A Lange; Stacy Tessler Lindau; Barry J Maron; Debra K Moser; E Magnus Ohman; Allen D Seftel; William J Stewart Journal: Circulation Date: 2012-01-19 Impact factor: 29.690
Authors: David C Pryde; Andrew S Cook; Denise J Burring; Lyn H Jones; Stephanie Foll; Michelle Y Platts; Vivienne Sanderson; Martin Corless; Alan Stobie; Donald S Middleton; Laura Foster; Laura Barker; Piet Van Der Graaf; Peter Stacey; Christopher Kohl; Sara Coggon; Kevin Beaumont Journal: Bioorg Med Chem Date: 2006-10-06 Impact factor: 3.641
Authors: Isabela Ribeiro Freitas; Marta Castro; Sofia Lourenço Sarmento; Cláudia Moura; Victor Viana; José Carlos Areias; Maria Emília Guimarães Areias Journal: BMJ Open Date: 2013-01-28 Impact factor: 2.692